Skip to main content
. 2018 Nov 26;2018:5340894. doi: 10.1155/2018/5340894

Table 2.

Characteristics of studies and lncRNAs expression related to DFS in GIC patients.

References lncRNAs (n = 37) Year Nations Number (n = 4360) DFS Cut-off value Detection methods Sample types Follow-up
HR 95% CI
Kong et al. [15]! PVT1↑ 2015 China 80GC 2.22∗ 1.13–4.44 Median RT-PCR Tissue <40
Liu et al. [17] FEZF1-AS1↑ 2017 China 82GC 1.52# 0.88–2.63 2-fold RT-PCR Tissue 1–43#
Fan et al. [30] LINC00261↓ 2016 China 138GC 1.81∗ 1.06–3.10 Median RT-PCR Tissue 20–48
Xu et al. [34] PVT1↑ 2017 China 190GC 1.75 1.25–2.56 Mean RT-PCR Tissue 1–85
Yuan et al. [35]! PVT1↑ 2016 China 111GC 2.21∗ 1.11–4.40 Median RT-PCR Tissue 20–48
Zheng et al. [37]! UCA1↑ 2015 China 112GC 2.55∗ 1.33–4.97 Dichotomize RT-PCR Tissue <92
Wang et al. [39]! CCAT2↑ 2016 China 108GC 2.31∗ 1.55–3.42 Median RT-PCR Tissue <70
Yue et al. [42]! FER1L4↓ 2015 China 70CC 4.51∗ 1.99–9.02 Median RT-PCR Tissue <80
Chen et al. [48]! H19↑ 2016 China 128GC 1.29∗ 1.00-1.65 Median RT-PCR Tissue 20–48
Zou et al. [49]! Sox2ot↑ 2016 China 155GC 3.84∗ 1.87–7.33 Median RT-PCR Tissue <70
Wang et al. [24] NR_034119↓ 2016 China 107CRC 1.93∗ 1.04–3.61 NR RT-PCR Serum 11–74
Wang et al. [52]! OTUB1-isoform 2↑ 2016 China 156GC 1.50∗ 1.02–2.20 Median RT-PCR Tissue <80
Liu et al. [59]! DANCR↑ 2015 China 104CRC 2.40∗ 1.39–7.28 Median RT-PCR Tissue <60
Wang et al. [60]! ZEB1-AS1↑ 2015 China 87EC 2.7 1.38–8.35 Median RT-PCR Tissue <61
Ma et al. [62]! PANDAR↑ 2016 China 100GC 2.36 1.15–4.83 NR RT-PCR Tissue 2–36
Peng et al. [65]! NEAT1↑ 2016 China 56CRC 2.39# 1.37–4.19 NR RT-PCR Tissue <60
Zhou et al. [69]! ROR↑ 2016 China 60CC 5.64∗ 1.92–16.58 Median RT-PCR Tissue <80
Yang et al. [70]! Loc554202↓ 2016 China 178CRC 2.75 1.55–7.93 Median RT-PCR Tissue <70
Peng et al. [75]! SPRY4-IT1↑ 2015 China 175GC 1.74∗ 1.32–2.48 Median RT-PCR Tissue <60
Nie et al. [76]! ZFAS1↑ 2016 China 54GC 1.83# 1.07–3.15 Median RT-PCR Tissue 3–36#
Xu et al. [79]a LSINCT5↑ 2014 China 71GC 1.08∗ 1.29–3.56 Mean RT-PCR Tissue <72
74CRC 1.30∗ 1.11–3.84 Mean RT-PCR Tissue <72
Sun et al. [80]! RP11-119F7.4↓ 2015 China 96GC 1.16# 0.81–1.65 Median RT-PCR Tissue <100
Zhang et al. [81]! ANRIL↑ 2014 China 120GC 1.72∗ 1.04–2.84 3-fold RT-PCR Tissue <60
Li et al. [82]! NEAT1↑ 2015 China 239CRC 1.80∗ 1.27–2.55 2-fold RT-PCR Tissue <60
Han et al. [84]! H19↑ 2016 China 83CRC 1.52∗ 1.30–1.90 3-fold RT-PCR Tissue <50
Cao et al. [87]! BC200↑ 2016 China 70EC 2.17∗ 1.12–4.19 Median RT-PCR Tissue <50
Wang et al. [90]! AFAP1-AS1↑ 2016 China 52CRC 2.12 1.03-4.35 Median RT-PCR Tissue <50
Sun et al. [93]! AK098081↑ 2016 China 84CRC 1.40# 0.86–2.28 Mean RT-PCR Tissue 1–118#
Xu et al. [94]! FENDRR↓ 2014 China 158GC 1.8 1.11–2.91 Median RT-PCR Tissue 20–48
Shang et al. [95] UCA1↑ 2016 China 77GC 2.54 1.09–5.92 NR RT-PCR Tissue <60
Fei et al. [103]! LINC00982↓ 2016 China 106GC 2.40∗ 1.19--4.81 Median RT-PCR Tissue 20–48
Chen et al. [104]! SNHG15↑ 2016 China 106GC 2.40∗ 1.38–4.18 Median RT-PCR Tissue 20–48
Liu et al. [108]! BANCR↑ 2016 China 142EC 3.42# 2.29–5.10 Median RT-PCR Tissue 1–60#
Wu et al. [113]! GHRLOS↓ 2017 China 366CRC 2.02∗ 1.42–2.88 1/2-fold RT-PCR Tissue 5–85
Yu et al. [114] linc00261↓ 2017 China 80GC 2.57∗ 1.39–4.20 NR RT-PCR Tissue <30
Ba et al. [120] LINC00673↑ 2017 China 79GC 2.94∗ 1.23–4.21 Median RT-PCR Tissue <50
Xu et al. [123] FOXD2-AS1↑ 2018 China 106GC 1.75∗ 1.04–2.97 Median RT-PCR Tissue 20–48

aOne study involved GC and CRC. ∗ indicates adjusted HR; # indicates calculated HR of DFS and follow-up time; ! indicates studies included OS and DFS; ↑ or ↓ indicates upregulated or downregulated with poor prognosis. OS: overall survival; DFS: disease-free survival; HR: hazard ratio; CI: confidence interval; EC: esophageal cancer; GC: gastric cancer; CRC: colorectal cancer; GIC: gastrointestinal cancer; NR: no report; RT-PCR: reverse transcription PCR.